SCHEDULE: Vanguard Group Maintains 7.81% Stake in Ardelyx Inc

The Vanguard Group reported a 7.81% beneficial ownership in Ardelyx Inc, totaling 18,979,483 common shares, following an internal realignment.

Summary

• The Vanguard Group holds beneficial ownership of 18,979,483 shares of Ardelyx Inc common stock.
• This represents 7.81% of the class of securities.
• Vanguard has shared voting power over 1,958,646 shares and shared dispositive power over 18,979,483 shares.
• An internal realignment occurred at The Vanguard Group, Inc. on January 12, 2026, where it ceased performing portfolio management services or administering proxy voting.
• Vanguard anticipates that certain subsidiaries or business divisions will report beneficial ownership separately in the future.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Ardelyx Inc.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-slightly-positive filing. While it's a routine disclosure, the continued significant institutional ownership by Vanguard is generally a positive signal for Ardelyx Inc, and the internal realignment is an administrative matter for Vanguard.

Positives

• Vanguard's continued significant stake (7.81%) in Ardelyx Inc indicates ongoing institutional interest.
• The filing clarifies Vanguard's internal operational changes, providing transparency to investors.

Negatives

• The internal realignment at Vanguard means the parent entity will no longer directly perform portfolio management or proxy voting, potentially leading to disaggregated reporting from subsidiaries, which could make tracking aggregate Vanguard ownership slightly more complex in the future.

Future Outlook

The Vanguard Group anticipates that certain subsidiaries or business divisions will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on SEC Release No. 34-39538 (January 12, 1998), following an internal realignment on January 12, 2026. These subsidiaries will pursue the same investment strategies.

Management Comments

• The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.
• No one other person's interest in the securities reported herein is more than 5%.
• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that institutional filings like this Schedule 13G provide transparency into significant ownership stakes, which is a standard practice in the investment management industry. The internal realignment at Vanguard reflects a broader trend among large asset managers to optimize operational structures and comply with evolving regulatory interpretations, potentially leading to more granular reporting from their various investment arms.

Stakeholder Impact

• Shareholders: Provides transparency regarding a major institutional investor's stake and its internal operational changes.
• Investment Professionals: Offers insight into Vanguard's continued investment in Ardelyx and its future reporting structure.

Next Steps

• Vanguard anticipates that certain subsidiaries or business divisions will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in the future.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure of beneficial ownership and an internal operational change at The Vanguard Group. It does not contain new information about Ardelyx Inc's financial performance, strategic direction, or material events that would warrant a change in investment recommendation. The continued significant institutional ownership by Vanguard is a neutral to slightly positive signal, but not enough to drive a 'buy' or 'sell' decision based solely on this filing. Investors should hold and await more substantive company-specific news.

Keywords

Ardelyx Inc, Vanguard Group, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Schedule 13G, Investment Management, Shareholding